Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Charles P. Vega, MD
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Ahmed Z. Obeidat, MD, PhD
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Brain Health in MS: A Comprehensive Approach
High-Efficacy DMTs: Transforming MS Care
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
Mastering ARIA Management: Charting the Path in a Virtual Clinic
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Perry B. Shieh, MD, PhD
Idiopathic Hypersomnia and Cardiovascular Health: Too Much of a Good Thing?
Logan Schneider, MD
Which Comes First? The Stimulant or the Oxybate?
Matthew Davis, MD
Alcibiades J. Rodriguez, MD, FAASM
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.